1 Conglomerate Stock You'll Be Happy You Own In 2032
Life sciences, diagnostics, and environmental science company Danaher (NYSE: DHR) served notice that it's on an excellent growth trajectory, even after the positive effect of the COVID-19 pandemic fades as it turns into an endemic. As such, the stock deserves a close look from investors looking for a relatively safe way to park money as the economy starts to slow, and for a stock to hold for the long term. Here's why.
The recently delivered second-quarter earnings report helped highlight the case for the stock and why it can deal with any economic recession. There are three key arguments:
The question of "What happens to Danaher after COVID-19?" is naturally at the front of investor thinking. After all, no one wants to pile into a stock on seemingly attractive valuations, just as its artificially boosted earnings are about to collapse and make the stock look extremely expensive.
Source Fool.com
